Loading
Latest filing published 21 Aug 2024 for Kiromic Biopharma, Inc., €524. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Brian Hungerford on record concern Kiromic Biopharma, Inc. Over a trading history stretching from 3 May 2024 to 19 August 2024, the count stands at 5 filings.
The open-market record is one-sided, with 4 purchases worth €9,068 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant.
A typical purchase (the median) is worth €2,681. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
On 21 August 2024 came the latest disclosure, an open-market purchase for €524 in Kiromic Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations